Genes Implicated In Myocardial Infarction Biology Essay

Published: Last Edited:

This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.

The aim of writing this review is a pre-research of the further experiment which is focus on the function of genes implicated in myocardial infarction in GWAS studies. This review will focus on the myocardial infarction, GWAS, genes loci, zebrafish and morpholino antisense. And list the three specific genes (PHACTR1, HHIPL1a and HHIPL1b) for further loci study.

The main complication of coronary artery disease, myocardial infarction

Cardiovascular disease is the leading causes of death and disability, it significantly increased in North America and Western Europe recently (McCarthyEt al. 2012, Hansson 2005). 38% of deaths in North America are caused by cardiovascular diseases, and it is also the most common causes of death in European men (under 65 years old). The most common diseases of cardiovascular disease is coronary artery disease (CAD) which is also the leading cause of death worldwide (Hansson 2005).

CAD is an inflammatory disease that interact with the metabolic circle for arterial system (ww). Coronary artery disease is result from assembled atherosclerosis plaques (fatty materials and plaques) in the coronary arteries that supply the blood for the heart muscle (myocardium) (Hansson, 2005). Coronary spasm may one of reasons for infarction, but most common cases are the thrombus of the surface of plaque (ww). The major narrow of the artery was owe to the blocks of blood flow by plaque, when the atherosclerosis plaques completely obstruct the blood flow incoronary arteries and shortage of oxygen in myocardium, it can lead to myocardial infarction (MI).(Hansson, 2005).

Myocardial infarction is also known as a heart attack and irreversible necrosis of myocardial. In clinic, myocardial infarction can be classified into non-ST-segment elevation myocardial infarction (non-STEMI) and ST-segment elevation myocardial infarction (STEMI).The typical symptoms of myocardial infarction are sudden chest pain, nausea, vomiting, palpitations, sweating and anxiety, but most of time, the myocardial infarction patients without any symptoms (Mallinson 2010). If amount of myocardium dead, it can leads to a severely heart failure. Normally, psychological stress or physical exertion rates are believed link to myocardial Infarction. For the most important risk factors, Yusuf et al. (2004) calculated the population attributable risks (PAR) of myocardial Infarction, and found that smoking and hypercholesterolemia account for about two-thirds of myocardial infarction. The dyslipidemia or hypercholesterolemia means the abnormal levels of lipoproteins in the blood, it express the low high-density lipoprotein, high low-density lipoprotein and high triglycerides. The increase risk factors of myocardial Infarction are hypertension, diabetes, abdominal obesity and diet (McCarthyet al.2012; Prins et al.2012; Scheffold et al.2011). According to Yusuf et al. (2004) research, ten risk factors account for 90% RAP in man and 94% in women affect the myocardial Infarction, there are smoking (PAR 35·7%), hypertension (PAR 17·9%), regular alcohol consumption (PAR 6·7%), diabetes (PAR 9·9%), hypertension (PAR 17·9%), psychosocial factors (PAR32·5%), history of abdominal obesity (PAR 20·1%), raised ApoB /ApoA1 ratio (PAR 49·2%), daily consumption of fruits and vegetables ( PAR 13·7%) and regular physical activity (PAR 12·2%). However, the first degree family history is strongly infect the risk of myocardial Infarction, it can increase 2 to 12 times risk compared with non-family history members. Myocardial Infarction is a complex disease with both environmental and genetic determinants (McCarthy et al.2012). In Scheffold et al.(2011) study, for the patients aged≤65 years in genetic factors of onset of myocardial Infarction, the men has more higher risk of MI than women, probably because the female sex hormones and also can caused by the different frequency of classical risk factory (hypertension, diabetes and smoking habits).

Genome-wide association studies (GWAS)

Genome-wide association study (GWAS) is an investigation method of genetic variants by study the association of inheritance genetic in different individuals. It focus on the linkage of single-nucleotide polymorphisms (SNPs), complex diseases and traits (Corneliset al.2010). In 2005, genome-wide association studies (GWAS) evident the specific DNA sequence differences can affect different people genetic susceptibility of over 40 diseases. Before GWAS, people use the genome-wide linkage study and linkage disequilibrium mapping as the methods. Linkage analysis, focus on association between illness and the alternative sequences of the markers which are closest to the disease-related genes (Psychiatric 2009). GWAS Study Design a sample, by selected a well-defined heritable phenotype, it conclude ill subjects and control subjects (Psychiatric 2009; Mannucciet al.2010).

Psychiatric (2009) Shown SNPs have different frequencies in different populations so we better choice the homogeneous samples. The genetic variants samples can be detected into four populations: Han Chinese, Japanese, Black African, and Caucasian (Mannucciet al.2010; Prins et al.2012). GWAS arrays major include common SNPs replace the rare variants. For the structure variation, a DNA segment variants can be deleted, rearranged or duplicated (Prinset al.2012).

As Mannucciet al.(2010) and Psychiatric (2009) mentioned, there are some principle of the GWAS we should considered. Firstly, not all of the diseases can be accountability to GWAS, such as a small samples or lower genotypic relatives SNPs, large-scale can be possible for GWAS. Secondly, current diagnostic methods may inadequate for large data collect. Then, the study may not correctly test the main effect SNPs caused by the error data interactions. Finally, there may have some unknown genetic mechanisms.

For the clinical field, the results of GWAS can be help for finding the new drug of therapy and prediction of different diseases. The current knowledge of genetic risk variants is not enough to identify the heritability of common diseases. The future steps of genetic research will focus on two directions: one is successfully translation the GWAS results through development clinical techniques. The other one is by collecting amount of data for helping genetic basis diseases in future research (Mannucciet al.2010).

Genetic loci in myocardial Infarction

The CAD gene database includes more than 300 genes. In 2002, the first genome-wide association study (GWAS) of myocardial Infarction researched 94 myocardial Infarction cases and 658 controls by using a genotyping array of >90,000 single nucleotide polymorphisms ( SNPs) in Japanese group. And point out LTA and LGALS2 as the susceptible loci. After that, Mannucciet al.(2010) research shown 13 loci genetic variation for the myocardial Infarction, and a locus on chromosome 9p21.3 identified successfully replicated in non-Caucasian populations lead to a high risk of myocardial Infarction. Prins et al. (2012) provided 32 genomic loci for the independent risk of myocardial Infarction.

Chromosome 1p13.3 is a second most replicated myocardial Infarction locus identified by GWAS (Coronary 2012; Erdmannet al.2009).SNP rs646776 is located in 97 kb haplotype block on 1p13.3. Chromosome 1p13.3 link to Low-Density Lipoprotein (LDL), total cholesterol, response to statin, Lp-PLA2 activity and progranulin level (Prins et al.2012). The allele SNP rs599839 is associated with Low-Density Lipoprotein cholesterol (LDL-C) and region harbors four genes: proline /serine-rich coiled coil protein 1 (PSRC1), cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2), myosin binding

protein H-like (MYBPHL) and sortilin 1 (SORT1) (Coronary 2012;Kleberet al.2010). The hepatic mRNA expression of PSRC1, CELSR2, and SORT1 has been shown to correlate with LDL-C plasma levels in a mouse model of cardiovascular disease and in a human cohort (Erdmann et al.2009). The CAD risk allele (A) was linked to a lower levels of CELSR2 and SORT1 expression and with higher levels of LDL-C. The (7) shown the SNP rs599839 genotype can be partly responsible for the health of cardio in minor G allele.

The SNP rs17465637 located on chromosome 1q41 with a high risk of myocardial Infarction by C allele (Erdmann et al.2009). This SNP rs17465637 on chromosome 1q41 is located in melanoma inhibitory activity family member 3 (MIA3) gene, which may leading higher risk of plaque formation by promote the migration of monocytic cells through fibrinogene or human microvascular endothelial cells . MIA3 gene is required for collagen VII (COL7A1) secretion by loading COL7A1 into transport cargo from the endoplasmic reticulum, and the MIA3gene is impressed as a tumor suppressor of malignant melanoma (Wanget al.2011).

SNP rs6725887 on chromosome 2q33 is located in intron 12 of the WD repeat domain 12 (WDR12) gene, which is a member of WD repeat protein family (WD40). This gene family is linked to cell cycle progression, apoptosis, signal transduction and gene regulation (Erdmannet al.2009).

Chromosome 3q22.3 SNP rs9818870 is located in the 3′ untranslated region of muscle RAS oncogene homolog (MRAS) gene which can widely expressed in all tissues, especially in cardiovascular system as a significant role in adhesion signaling (Erdmann et al.2009).

Erdmann et al.(2009) shown that the SLC22A3-LPAL2-LPA gene cluster is strongly associated with myocardial Infarction, for chromosome 6P26-27, the four SNPs rs2048327 in SLC22A3 gene, rs7767084 in the LPA gene, rs3127599 in the LPAL2 gene and rs10755578 in the LPA gene are the high risk of myocardial Infarction. The chromosomes are linked to Lipoprotein (a) which is a main protein of coronary artery disease (CAD).

The chromosome 9p21 play an important role in myocardial Infarction, and play as a strongest common genetic factors linked to the risk of coronary artery disease (CAD) in European ancestry(Saleheen et al.2012). (Scheffoldet al.2012) research shown the 240 kilobases (kb) at chromosome 9p21 (chr9:21936711-22176221, hg18) associated with the type 2 diabetes and myocardial infarction in 47 unrelated individuals from Northern and Western European .635 high-confidence SNPs and 257 genotype sites are be identified at chromosome 9p21 by Using targeted sequencing(Shea et al.2011). The International HapMap Project CAU is a population of Northern and Western European ancestry.21 variants on chromosome 9p21 are been identified associated with coronary artery disease by analysis of 38 250 CAD cases and 84 820 controls in Europeans (Shea et al.2011). The nearby genes in three human tissues (liver, visceral fat and subcutaneous fat) are explored to related with 9p21.3 SNP in Myocardial (2009) study. The (Scheffoldet al.2012) mentioned there are six SNPs represented on the chromosome 9p21.3 (rs1333049, rs1333040, rs10757274, rs10757278, rs2383206 and rs2383207). Among of them, two SNPs rs10757274 and rs2383206 are linked to myocardial infarction and located with a locus spanning 58 kb region on chromosome 9p21.3. For other three SNPS rs1333040, rs2383207 and rs10757278 on chromosome 9p21 are linked to myocardial infarction , This also shown in Erdmann et al.(2009) search, each C alleles of SNP rs1333049 on chromosome 9p21 can increased 22% higher risk of myocardial Infarction or coronary artery disease. Variant studies shown the risk of chromosome 9p21 in different diseases. Two haplotype-tagging SNPs (rs1333049 and rs1412832) were associated with myocardial infarction Pakistanis (Shea et al.2011).The same SNPs are reported to relevant the type 2 diabetes mellitus (T2DM), chromosome 9p21.3is related to antisense non coding RNA in the INK4 locus ( ANRIL) for activity independently of T2DM. Chromosome 9p21 is also contribute to the risk of glioma (Erdmann et al.2009). SNP rs4977574 on chromosome 9p21 with mRNA level of cyclin-dependent kinase inhibitor 2B (CDKN2B) are strongly relevant to intracranial aneurysm, abdominal aortic aneurysm and Type 2 diabetes (Prinset al.2012).). A variant at chromosome 9p21 adjacent to cyclin-dependent kinase inhibitor 2A and 2B (CDKN2A and CDKN2B) are related with cell carcinoma, and variant at 9p21 near methylthioadenosinephosphorylase ( MTAP) and CDKN2A associated with familial melanoma(Erdmann et al.2009). The Saleheen et al.(2012) also identified the three near genes are in higher linkage disequilibrium (LD) and span 58 kb region. The three neighboring protein coding genes (CDKN2A, CDKN2B and MTAP) were relevant with cell cycle progress, cellular senescence, cellular proliferation and apoptosis. SNP rs4977574 was linked to level of CDKN2B transcript in visceral fat tissue that replace in human liver (Myocardial 2009). SNP score is comparable in predictive value to plasma LDL cholesterol 28. Recent report shown the LTA4H haplotype associated with MI in Africans and TCF7L2 linked to type 2 diabetes mellitus in West Africans (Saleheen et al.2012).

The SNP rs501120 located on chromosome 10q11.21 located in 5 region of the Stromal-derived factor 1(SDF1) gene in T allele, has shown a higher risk of myocardial infarction. SDF-1 gene is a member of the chemokine family which has related to atherosclerotic plaques. The CXCR4 receptor is express in endothelial and monocytes cells and SDF1 gene is the only ligand of the CXCR4 receptor. The effect of the SDF1 and CXCR4 receptor are regulate monocyte inflammatory response and endothelial progenitor cells. If the SDF1 and CXCR4 receptor overexpressed, it will link to maintain atherosclerotic plaques by endothelial progenitor cell recruitment and inflammation (Erdmannet al.2009). The Coronary (2009) shown the CXCL12 on SDF1 gene located on chromosome 10q11.21 is significant in stem cell homing, and angiogenesis promoting. For this genetic loci, men has higher risk of myocardial infarction than women.

The minor T allele of SNP rs9982601 on chromosome 21q22 increase the risk of myocardial infarction, this SNP is associated with MRPS6, SLC5A3 and KCNE2 as an intergenic region, KCNE2 is a inferior of potassium(K) channel and mutate of this encode can cause inherited arrhythmias. The SNP rs9982601 variants in noncoding transcript instead of change three protein coding genes which mentioned above. SNP rs2259816 on chromosome 21q22 located in intron 7 of the hepatocyte nuclear factor-1 a( HNF1A) gene, the HNF1A encode a transcription factor binds to express variants of genes in liver, and effect plasma concentrate of C-reactive protein(Erdmann et al.2009) .


Phospjatase and actin regulator 1 (PHACTR1) is associated with a common C allele of SNP rs12526453 on chromosome 6p24 (Erdmann et al.2009;Wang et al.2011). PHACTR1is an unidentified potential biomarker of endothelial cells (Patel et al.2011) .The PHACTR1 is an enzyme which dephosphorylates serine and threonine residues on a range of proteins, and an protein phosphatase 1 inhibitor. PP1 shown a increased in end stage heart failure in patients (Wang et al.2011). PHACTR1 is a member of the PHACTR/ Scapinin family which content four members (PHACTR-1 to PHACTR-4). PHACTR-3 transcripts are found in heart and in leukaemia, lung cancer and melanoma. In humdy mouse, a mutation of PHACTR-4 is responsible for serious disorder in the early development of the CNS. PHACTR-1 protein not expressed in brain, but highly found in the striatum, hippocampusand heart. PHACTR-1 is a VEGF-dependent gene which activity in human endothelial cells. VEGF is a significant factors for the blood vessel formation. For VEGFA165-dependent proteins play an important role in angiogenesis. In human endothelial cells, PHACTR-1-depleted HUVECs increased cell death, and reduced in tube formation. On PHACTR-1 knockdown, cytotoxicity and inhibition of tube formation related with the involvement of apoptosis. Apoptosis can be triggered into two pathways: an extrinsic pathway and an intrinsic pathway (the mitochondria-dependent pathway) (Patel et al.2011). SNPs rs499818, rs1512411, rs507369 and rs9349379 are located in an intron of PHACTR1 (Mehta 2011). In more than 1000 participants in an independent GWAS for coronary artery, PHACTR1 has been identified be related to calcification (Erdmann et al.2009). The OHACTR1 is phosphatase and act in regulator, the location of human is in chromosome 6:12717893-13288645:1. SNP rs9349379 in PHACTR1 with arterial stenosis is associated with the early onset of myocardial infarction, rs9349379 may a better marker than rs12526453. The relevant was highest in the left anterior descending artery and lowest in the left main artery if the specific main vessels were used as a alone outcome (Patel et al.2011).

The chromosome 14q32 located in Hedgehog interacting protein like 1(HHIPL1) associated with myocardial infarction. HHIPL1 is an antagonist of the Hedgehog (HH) family of proteins, and HHIPL1 is major in normal vascular development in vivo study. All of the variants in the 25kb CAD linkage obstruct at the 14q32 locus are situated within the introns of the HHIPL1 gene. HHIPL1a and HHIPL1b also linked to the function on angiogenesis, thrombosis and vascular permeability (Prinset al.2012).


The zebrafish (Daniorerio) is a small freshwater fish which covered with iridescent scales and black stripes, it is a tropical fish and popular in home aquarium in decades (Quaifeet al.2012). The zebrafish is only 4cm in length and live up to 5 years, Zebrafish (Daniorerio) originated in the streams of Southeast Asia (Chico et al.2008), the Quaife et al.(2012) also mentioned it breed in India's Ganges River. Since 1990s, the zebrafish has been widely used in helping biomedical research to learn more about our hearts function and develop in lab. A adults female zebrafish can produce about 300 eggs per week, that are fertilized by males. If the eggs fertilized, it almost transparent immediately(Chico et al.2008). These eggs developed rapidly with all major organs appear within 36 hours, after 24 hours a two chambered heart has developed, and the axial aorta and vein have been formed, after following days, the main vascular developed. And hatch will take place after 48 hours. After that the blood flow can been seen in all patent vessels with cardiac contraction commences in 24 hours (Quaifeet al.2012).The whole grow up and reproduce will take place about three months. Small molecular can be added into the incubate milieu by the embryo's aquatic milieu. The reason of using zebrafish to research the mysteries of heart diseases is the no beating heart can survive and grow for several days even the embryos develop severely malformed, and also caused of the rapid breeding, abroad available and cheap price. The early embryo can obtain sufficient oxygenation via diffusion without require a circulation. So the embryos stages are fatal for phenotypes study in mammals that without cardiac contraction or blood flow (Quaife et al.2012; Nemtsaset al.2010).The zebrafish is a vertebrate model that genetic, embryological and physiological methods can be easily applied. Although zebrafish only has two-chamber, physiology of the zebrafish and the human heart is similar in many aspects (Nemtsaset al.2010).

By compare with human and zebrafish hearts, both of their heart muscles are designed to pump oxygen carrying blood through the body, and their all have the valves to ensure the blood flows in the correct direction in heart chambers. The regular and rhythmic of heart beat is also the common character .The common of human and zebrafish is in terms of QT interval even the zebrafish lack of pulmonary vasculature, and both of the heart wrap by a pericardial sac. The bulbous arteriosus in zebrafish is similar to human aortic arch with thick contractile smooth muscle. For blood return, the sinus venosus in zebrafish is similar as vena cava in human (SUN et al. 2009). Cause by that, the scientists using zebrafish to research the human heart disorder by collecting the zebrafish mutants. For the different of the zebrafish and human heart is the electrical activity which shown on robust T type Ca2+ in atrial and ventricular.

myocytes of the zebrafish heart (Nemtsaset al.2010).According to the transparency of embryo, it make a model of angiogenesis and organogenesis. The amount of fibrotic tissues can stiffen the ventricles and obstruct the contraction and relaxation of heart. After infarction of up to 20% ventricular resection within two months, the zebrafish can fully regenerate their myocardium. Compare ventricular resection with cryoinjury, the later can results in more cell death in ventricular wall by using electrocardiograms (ECGs) (Chablaiset al.2011). Recent research of assessment heart regeneration is use the molecular and histological methods (SUN et al. 2009;Chablais et al.2011).The González-Rosa et al. (2011) research shown the after cryocauterization (CC) the zebrafish heart is able to completely regenerate. 25% of cryocauterization of the zebrafish ventricle after completely regenerate of coronary vasculature, myocardium and endocardium. A prominent collagen deposition forms of cryocauterization model can better resemble the fibrotic scars formed than ventricular apex resection (VR).In heart regeneration, the scar not inhibit the cardiomyocyte proliferation in zebrafish, scar is reversible by it is gradually removed in zebrafish(González-Rosa et al. 2011).

Morpholino antisense oligonucleotides

Morpholino antisense oligonucleotides is a technology that used to obstruct other molecules to specific sequences within nucleic acid. It provide a useful approach to investigate gene function in zebrafish embryos (Corey&Abrams2001; Yuan & Sun 2009). Antisense ohgos is oligonucleotides, oligonucleotide analogs and other specific sequence that block of selected messenger RNAs (mRNA). If the antisense oligo linked to targeted disease sequence, it can release the activity of target. By using antisense oligos can provide the prospect safety and effective therapeutics for several diseases(Corey & Abrams 2001).The advantage of morpholinos is that provide the nuclease resistance, long-term activity, equisite specificity and lower toxicity. Morpholino antisense oligonucleotides (MO) can binds to complementary nucleic acid sequences of Watson-Crick base pairing. For oligonucleotides cells, an antisense oligonucleotide to down-regulate gene expression must penetrate into the targeted cells.A major block of using antisense oligonucleotides is choosing a target sequence. Antisense oligonucleotides are able to form RNA-DNA hybrids, RNase H can promotes the mRNA target split through this hybrid. Morpholino antisense oligomers can be used for generating mutant phenotypes as a routine tool. Morpholino oligonucleotides has high success rate for the inhibition of gene expression.More than 40 oligonucleotides need to be tested for identify one that efficiently inhibits gene expression(Corey&Abrams 2001).Over 20 years ago, it began to develop antisense RNA, process and stability of endogenous into a cell for inhibit the translation. In zebrafish, antisense RNA is widely used and effect sequence independent. In this century, the MOs has been used for targeted to knockdown specific gene expression in frog and zebrafish (Eisen&Smith 2008). Determine zebrafish effectiveness and properly interpret the link of morphant phenotype is an assessment of the knockdown efficiency of MO. MOs are synthetic oligonucleotides composed of chains and have a morpholine ring rather than a ribose ring. MOs are resistant and stable to nucleases and do not carry a negatively charged backbone, itshown that they areless likely to interact non-specifically with other composed of thecell and less toxic. The luciferase assay system is used to measure the knockdown efficiency of MOs in zebrafish embryos. Many experiments use MOs against the initiation codon of the target mRNA directly. This approach is activity in genome sequence unknown species, because one does not need to know the intron-exonstructure of the target gene to inhibit its function(Eisen&Smith 2008). Targeted the chordin (chd) gene encoding a BMP antagonist, chd-MO molecule has been established, they designed another MO (chd-MO2), to complementto the 50-UTR of the zebrafish chd mRNA. By observed the synergistic effect between chd-MO1 and -MO2we can known the inhibition of luciferase expression was very consistent in the chordinmorphant embryos. The study shown the most efficientMOs cause more than 80% inhibition of translation and major knockdown effects in zebrafish embryos when used singlyat 1-2 ng/embryo, by using double MO strategy can gave over 90% decreased of protein expression in all of the cases tested. Oligonucleotidesantisense also depends on temperature, cell line, structure and the concentration of the oligonucleotide . With long-term therapeutic effect, adeno-associated virus-mediated production of antisense oligonucleotides(AO) hasshown to be highly effective for targeted exon in bothlocally and systemically. Thisapproach has strongly advantage to synthetic AOs by eliminate the need for repeated injections. Antisense oligomers (ASO) include 2-O-methoxyethyl (MOE)-modified nucleotides on a phosphorothioatebackbone, phosphorodiamidatemorpholino oligomers (MO) andpeptide nucleic acids (PNA) , be provided as specific splice-switching agents to alter pre-mRNAprocessing.

For microinjection of mRNA and Morpholino Antisense Oligonucleotides in ZebrafishEmbryos, we have 8 processes in Yuan & Sun (2009)..Firstly,preparation of micropipettes and microinjection chamber plates by heating and pulling glass capillary tubes, and pouring 1.5% agarose. Secondly, preparate of RNA. Perform an in vitro CAP RNA transcription reaction on your transcript of interest, purify the RNA sample, concentrate the RNA preparation and inject the sample is what we should do in this step. Then, preparate of morpholino. After that, filling the micropipette with your working solution by the diatel end of the micropipette.At the fifth steps, calibrating the micropipette injection volume by adjust, inject and use of the pressure-pulsed micro injector apparatus. Sixth, preparing fertilized zebrafish embryos for microinjection. Zebrafish will randomly mate in the first few hours of each morning, collect and shallow embryos. In seven steps, microinjection through the chorion, manipulate the embryos with the micropipette, penetrate the chorion and the yolk with micropipette for inject into the embryo, incubate the embryos and observe it. Finally, representative results(Yuan & Sun 2009).


In recent year the GWAS identified dozens of gene loci of increase risk of myocardial infarction, this review give a background of the gene loci in myocardial infarction in GWAS studies and introduce zebrafish as the attractive tool for identified the function of three specific genes, and give the reason of why we try to use morpholino antisense to knockdown genes in zebrafish embryos.